SEI Investments’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.12M Sell
142,858
-23,619
-14% -$1.05M 0.01% 1236
2026
Q1
$4.95M Buy
166,477
+32,882
+25% +$983K ﹤0.01% 1543
2025
Q4
$5.1M Buy
133,595
+84,163
+170% +$2.74M 0.01% 1362
2025
Q3
$1.18M Sell
49,432
-30,710
-38% -$577K ﹤0.01% 1909
2025
Q2
$1.19M Buy
80,142
+47,730
+147% +$791K ﹤0.01% 1848
2025
Q1
$581K Buy
32,412
+1,607
+5% +$32.6K ﹤0.01% 2094
2024
Q4
$537K Buy
30,805
+213
+0.7% +$3.77K ﹤0.01% 2165
2024
Q3
$428K Buy
30,592
+16,366
+115% +$171K ﹤0.01% 2234
2024
Q2
$117K Buy
+14,226
New +$95.8K ﹤0.01% 2513
2021
Q2
Sell
-8,025
Closed -$219K 2637
2021
Q1
$219K Sell
8,025
-5,844
-42% -$161K ﹤0.01% 2363
2020
Q4
$378K Sell
13,869
-36,513
-72% -$852K ﹤0.01% 2106
2020
Q3
$930K Buy
+50,382
New +$979K ﹤0.01% 1633
2019
Q2
Sell
-584
Closed -$16K 2767
2019
Q1
$16K Sell
584
-133
-19% -$2.94K ﹤0.01% 2770
2018
Q4
$19K Buy
717
+100
+16% +$2.49K ﹤0.01% 2502
2018
Q3
$17K Sell
617
-4,543
-88% -$130K ﹤0.01% 2392
2018
Q2
$141K Buy
+5,160
New +$137K ﹤0.01% 2171
2016
Q2
Sell
-400
Closed -$5K 2754
2016
Q1
$5K Buy
+400
New +$6.07K ﹤0.01% 2283
2015
Q4
Sell
-16,703
Closed -$338K 2689
2015
Q3
$338K Buy
+16,703
New +$495K ﹤0.01% 1437

Other funds holding TVTX

SEI Investments's TVTX Position: Q2 2026 in Review

SEI Investments reduced its Travere Therapeutics (TVTX) stake by 14% in Q2 2026, selling an estimated $1.05M and leaving 142,858 shares worth $8.12M. The position accounts for 0.01% of the portfolio, ranked #1236.

SEI Investments first reported a position in TVTX in Q3 2015 and has held it in 18 quarters since. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • SEI Investments held 142,858 shares of Travere Therapeutics worth $8.12M as of Q2 2026.
  • SEI Investments sold 23,619 Travere Therapeutics shares in Q2 2026, an estimated $1.05M.
  • Travere Therapeutics made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1236 holding.
  • SEI Investments first reported a position in Travere Therapeutics in Q3 2015 and has held it in 18 quarters since.
  • 320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.